CeriBell, Inc. Comprehensive Income
CeriBell, Inc. (CBLL) reported Comprehensive Income of -$19.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-10
- CeriBell, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$19.38M.
- CeriBell, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$19.88M.
- CeriBell, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$13.51M.
- CeriBell, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$13.33M.
- CeriBell, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$53.25M.
- CeriBell, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$40.45M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.38M 10-Q · filed 2026-08-10 | -$39.26M 10-Q · filed 2026-08-10 | -$52.76M derived: sum of 3 quarters · filed 2026-08-10 | -$66.09M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$19.88M 10-Q · filed 2026-05-11 | -$33.38M derived: sum of 2 quarters · filed 2026-05-11 | -$46.72M derived: sum of 3 quarters · filed 2026-05-11 | -$60.35M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$13.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$26.84M derived: sum of 2 quarters · filed 2026-02-24 | -$40.47M derived: sum of 3 quarters · filed 2026-08-10 | -$53.25M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$13.33M 10-Q · filed 2025-11-04 | -$26.96M derived: sum of 2 quarters · filed 2026-08-10 | -$39.75M 10-Q · filed 2025-11-04 | -$52.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$13.63M 10-Q · filed 2026-08-10 | -$26.41M 10-Q · filed 2026-08-10 | -$38.99M derived: sum of 3 quarters · filed 2026-08-10 | -$49.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$12.78M 10-Q · filed 2026-05-11 | -$25.36M derived: sum of 2 quarters · filed 2026-05-11 | -$35.78M derived: sum of 3 quarters · filed 2026-05-11 | -$44.72M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$22.99M derived: sum of 2 quarters · filed 2026-02-24 | -$31.93M derived: sum of 3 quarters · filed 2026-02-24 | -$40.45M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$10.42M 10-Q · filed 2025-11-04 | -$19.36M derived: sum of 2 quarters · filed 2025-11-04 | -$27.88M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | -$8.94M 10-Q · filed 2025-08-05 | -$17.46M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$8.52M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |